RT Journal Article
SR Electronic
A1 Vinall, Phil
T1 Negative Florbetaben PET Scan Excludes the Presence of Amyloid Pathology
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 6
SP 9
OP 10
DO 10.1177/155989771406005
UL http://mdc.sagepub.com/content/14/6/9.2.abstract
AB There is a strong correlation between florbetaben (an F-labeled β-amyloid-targeted tracer) uptake and amyloid pathology. This article presents results of the Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-Amyloid Compared to Histopathology trial (ClinicalTrials.gov identifier NCT01020838). These results support the use of florbetaben as a valuable diagnostic tool for the exclusion of Alzheimer's disease or differential diagnosis of dementia as the cause of cognitive decline.